Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation

Colover, 1958, Experimental iso-immune adrenalitis, Immunology, 1, 172 Wehbeh, 2019, Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease, Expert Rev Endocrinol Metab, 14, 167, 10.1080/17446651.2019.1598260 Ferrari, 2019, Autoimmune endocrine dysfunctions associated with cancer immunotherapies, Int J Mol Sci, 20, 2560, 10.3390/ijms20102560 Koch, 2018, Immunoendocrinology: when (neuro) endocrinology and immunology meet, Rev Endocr Metab Disord, 19, 277, 10.1007/s11154-018-9479-7 Falorni, 2014, Diagnosis and classification of autoimmune hypophysitis, Autoimmun Rev, 13, 412, 10.1016/j.autrev.2014.01.021 Bellastella, 2016, Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects, Pituitary, 19, 625, 10.1007/s11102-016-0736-z Buxton, 2001, Lymphocytic and granulocytic hypophysitis: a single centre experience, Br J Neurosurg, 15, 242, 10.1080/02688690120057664 Caturegli, 2005, Autoimmune hypophysitis, Endocr Rev, 26, 599, 10.1210/er.2004-0011 Chiloiro, 2017, An overview of diagnosis of primary autoimmune hypophysitis in a prospective single-center experience, Neuroendocrinology, 104, 280, 10.1159/000446544 Joshi, 2018, Mechanisms in endocrinology: hypophysitis: diagnosis and treatment, Eur J Endocrinol, 179, R151, 10.1530/EJE-17-0009 Caturegli, 2014, 633 Yamamoto, 2019, Autoimmune pituitary disease: new concepts with clinical implications, Endocr Rev, bnz003, 10.1210/endrev/bnz003 Shikuma, 2017, Critical review of IgG4-related hypophysitis, Pituitary, 20, 282, 10.1007/s11102-016-0773-7 Caturegli, 2008, Pituitary autoimmunity: 30 years later, Autoimmun Rev, 7, 631, 10.1016/j.autrev.2008.04.016 Gubbi, 2018, Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions, Rev Endocr Metab Disord, 19, 335, 10.1007/s11154-018-9480-1 Lupi, 2011, Diagnosis and treatment of autoimmune hypophysitis: a short review, J Endocrinol Investig, 34, e245 Chiloiro, 2019, The changing clinical spectrum of hypophysitis, Trends Endocrinol Metab, 30, 590, 10.1016/j.tem.2019.06.004 Simmonds, 1917, Über das Vorkommen von Riesenzellen in der Hypophyse, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin, 223, 281 Goudie, 1962, Anterior hypophysitis and Hashimoto's disease in a young woman, J Pathol Bacteriol, 83, 584, 10.1002/path.1700830241 Caturegli, 2016, Hypophysitis secondary to cytotoxic T-lymphocyte–associated protein 4 blockade: insights into pathogenesis from an autopsy series, Am J Pathol, 186, 3225, 10.1016/j.ajpath.2016.08.020 Angelousi, 2018, Clinical, endocrine and imaging characteristics of patients with primary hypophysitis, Horm Metab Res, 50, 296, 10.1055/s-0044-101036 Imber, 2015, Hypophysitis: a single-center case series, Pituitary, 18, 630, 10.1007/s11102-014-0622-5 Guay, 1987, Lymphocytic hypophysitis in a man, J Clin Endocrinol Metab, 64, 631, 10.1210/jcem-64-3-631 Laway, 2013, Pregnancy and pituitary disorders: challenges in diagnosis and management, Ind J Endocrinol Metabol, 17, 996, 10.4103/2230-8210.122608 O’dwyer, 2002, Pituitary autoantibodies in lymphocytic hypophysitis target both γ-and a-enolase–A link with pregnancy?, Arch Physiol Biochem, 110, 94, 10.1076/apab.110.1.94.897 Tsur, 1996, Successful pregnancy in a patient with preexisting lymphocytic hypophysitis, Acta obstetricia et gynecologica Scandinavica, 75, 772, 10.3109/00016349609065747 1999, Histologically proven lymphocytic hypophysitis: spontaneous resolution and subsequent pregnancy Hayes, 1996, The occurrence of lymphocytic hypophysitis in a first but not subsequent pregnancy, J Clin Endocrinol Metab, 81, 3131 Chandan, 2017, Recurrent lymphocytic hypophysitis during two pregnancies: a very rare care, Soc Endocrinol BES, 2017 Davies, 2016, An atypical case of lymphocytic panhypophysitis in a pregnant woman, J Neuro Ophthalmol, 36, 313 Sakurai, 2017, Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy, Endocr J, 64, 645, 10.1507/endocrj.EJ17-0028 Panicker, 2005, Presumed infundibuloneurohypophysitis: unusual presentation in a postpartum patient, Am J Neuroradiol, 26, 357 Fehn, 1998, Lymphocytic hypophysitis: light and electron microscopic findings and correlation to clinical appearance, Endocr Pathol, 9, 71, 10.1007/BF02739954 Gutenberg, 2005, Immunopathology of primary hypophysitis: implications for pathogenesis, Am J Surg Pathol, 29, 329, 10.1097/01.pas.0000149707.12335.8e Mirocha, 2009, T regulatory cells distinguish two types of primary hypophysitis, Clin Exp Immunol, 155, 403, 10.1111/j.1365-2249.2008.03828.x O’dwyer, 2002, Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as α-enolase, J Clin Endocrinol Metab, 87, 752, 10.1210/jcem.87.2.8205 Takao, 2001, Antipituitary antibodies in patients with lymphocytic hypophysitis, Hormone Res Paediat, 55, 288, 10.1159/000050015 Tanaka, 2003, Anti-alpha-enolase antibodies in pituitary disease, Endocr J, 50, 697, 10.1507/endocrj.50.697 De Bellis, 2012, Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells, J Clin Endocrinol Metab, 97, 3684, 10.1210/jc.2012-2269 Andrioli, 2006, Isolated corticotrophin deficiency, Pituitary, 9, 289, 10.1007/s11102-006-0408-5 De Bellis, 2016, Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age, Eur J Endocrinol, 174, 381, 10.1530/EJE-15-0766 Iwama, 2013, Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells, J Clin Endocrinol Metab, 98, 3920, 10.1210/jc.2013-2411 Cocco, 2014, Pituitary gonadotropins and autoimmunity, Mol Cell Endocrinol, 385, 97, 10.1016/j.mce.2013.10.009 Bellastella, 2003, Lymphocytic hypophysitis: a rare or underestimated disease?, Eur J Endocrinol, 149, 363, 10.1530/eje.0.1490363 Heaney, 2015, HLA markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis, J Clin Endocrinol Metab, 100, 4092, 10.1210/jc.2015-2702 Prete, 2000, Hypophysitis Hunn, 2014, Idiopathic granulomatous hypophysitis: a systematic review of 82 cases in the literature, Pituitary, 17, 357, 10.1007/s11102-013-0510-4 Guaraldi, 2017, vol. 48, 48 Tzou, 2008, Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model, Endocrinology, 149, 3461, 10.1210/en.2007-1692 Kamisawa, 2003, A new clinicopathological entity of IgG4-related autoimmune disease, J Gastroenterol, 38, 982, 10.1007/s00535-003-1175-y Bando, 2014, The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature, Eur J Endocrinol, 170, 161, 10.1530/EJE-13-0642 Yuen, 2018, A case series of atypical features of patients with biopsy-proven isolated IgG4-related hypophysitis and normal serum IgG4 levels, Pituitary, 21, 238, 10.1007/s11102-017-0852-4 van der Vliet, 2004, Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis, Ann Intern Med, 141, 896, 10.7326/0003-4819-141-11-200412070-00033 Wong, 2007, Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease, Hum Pathol, 38, 1720, 10.1016/j.humpath.2007.06.011 Bernreuther, 2017, IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis, Brain Pathol, 27, 839, 10.1111/bpa.12459 Leporati, 2011, IgG4-related hypophysitis: a new addition to the hypophysitis spectrum, J Clin Endocrinol Metab, 96, 1971, 10.1210/jc.2010-2970 Uccella, 2019, Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature, Virchows Arch, 1 Kamisawa, 2015, IgG4-related disease, Lancet, 385, 1460, 10.1016/S0140-6736(14)60720-0 Folkerth, 1998, Xanthomatous hypophysitis, Am J Surg Pathol, 22, 736, 10.1097/00000478-199806000-00011 Gutenberg, 2006, Primary hypophysitis: clinical-pathological correlations, Eur J Endocrinol, 155, 101, 10.1530/eje.1.02183 Yuen, 2019, New causes of hypophysitis, Best Pract Res Clin Endocrinol Metabol, 33, 101276, 10.1016/j.beem.2019.04.010 Kleinschmidt-DeMasters, 2017, Review of xanthomatous lesions of the sella, Brain Pathol, 27, 377, 10.1111/bpa.12498 Gutenberg, 2012, Necrotizing infundibulo-hypophysitis: an entity too rare to be true?, Pituitary, 15, 202, 10.1007/s11102-011-0307-2 Ahmed, 1993, Necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism, J Clin Endocrinol Metab, 76, 1499 Ćaćić, 2018, Ischemic pituitary apoplexy, hypopituitarism and diabetes insipidus: a triad unique to necrotizing hypophysitis, Acta Clin Croat, 57, 768 Tashiro, 2002, Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases, Endocr Pathol, 13, 183, 10.1385/EP:13:3:183 Faje, 2019, Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis, Eur J Endocrinol, 1 Byun, 2017, Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies, Nat Rev Endocrinol, 13, 195, 10.1038/nrendo.2016.205 Pardoll, 2012, The blockade of immune checkpoints in cancer immunotherapy, Nat Rev Cancer, 12, 252, 10.1038/nrc3239 Albarel, 2015, Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma, Eur J Endocrinol, 172, 195, 10.1530/EJE-14-0845 Faje, 2014, Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma, J Clin Endocrinol Metab, 99, 4078, 10.1210/jc.2014-2306 Min, 2015, Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study, Clin Cancer Res, 21, 749, 10.1158/1078-0432.CCR-14-2353 Wei, 2019, Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population, Melanoma Manag, 6, MMT13, 10.2217/mmt-2018-0009 Barroso-Sousa, 2018, Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis, JAMA Oncol, 4, 173, 10.1001/jamaoncol.2017.3064 Iwama, 2014, Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody, Sci Transl Med, 6, 10.1126/scitranslmed.3008002 Lupi, 2019, Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases, Endocrinol Diab Metabol Case Rep, 2019 Faje, 2018, High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma, Cancer, 124, 3706, 10.1002/cncr.31629 Bayram, 1998, Lymphocytic hypophysitis in a patient with Graves' disease, J Endocrinol Investig, 21, 193, 10.1007/BF03347301 2018, vol. 2018 Bando, 2015, Anti-PIT-1 antibody syndrome; a novel clinical entity leading to hypopituitarism, Pediatr Endocrinol Rev, 12, 290 Katano, 1998, Visual disturbance by lymphocytic hypophysitis in a non-pregnant woman with systemic lupus erythematosus, Lupus, 7, 554, 10.1191/096120398678920514 Ashraf, 2009, Primary Sjögren's syndrome manifesting as multiple cranial neuropathies: MRI findings, Ann Indian Acad Neurol, 12, 124, 10.4103/0972-2327.53083 Tao, 2018, Lymphocytic hypophysitis associated with Behcet's disease: a case report and review of the literature, Neuroendocrinol Lett, 39 Chiloiro, 2018, Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients, Clin Endocrinol, 88, 692, 10.1111/cen.13566 McIntyre, 2007, Fatal inflammatory hypophysitis, Pituitary, 10, 107, 10.1007/s11102-007-0016-z Chu, 2019, Granulomatosis with polyangiitis presenting as hypophysitis, Am J Med, 132, e21, 10.1016/j.amjmed.2018.09.004 Funauchi, 2002, Microscopic polyangitis as a possible cause of diabetes insipidus, Clin Rheumatol, 21, 540, 10.1007/s100670200134 Toth, 1996, Granulomatous hypophysitis associated with Takayasu's disease, Clin Endocrinol, 45, 499, 10.1046/j.1365-2265.1996.8110821.x Kanatani, 1991, Hypopituitarism associated with Cogan's syndrome; high-dose glucocorticoid therapy reverses pituitary swelling, Jpn J Med, 30, 164, 10.2169/internalmedicine1962.30.164 Chan, 2004, Panhypopituitarism in association with interferon-alpha treatment, Singap Med J, 45, 93 Ridruejo, 2006, Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin, Eur J Gastroenterol Hepatol, 18, 693, 10.1097/00042737-200606000-00019 Tebben, 2007, Granulomatous adenohypophysitis after interferon and ribavirin therapy, Endocr Pract, 13, 169, 10.4158/EP.13.2.169 Ramos-Leví, 2018, Hypophysitis following treatment with ustekinumab: radiological and pathological findings, Front Endocrinol, 9, 83, 10.3389/fendo.2018.00083 Marinelli, 2019, Skull base manifestations of Erdheim-Chester disease: a case series and systematic review, Neurosurgery, 85, E693, 10.1093/neuros/nyz027 Imashuku, 2011, Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis, Int J Hematol, 94, 556, 10.1007/s12185-011-0955-z Pal, 2019, Intracranial germinoma masquerading as secondary granulomatous hypophysitis: a case report and review of literature, Neuroendocrinology, 10.1159/000501886 Li, 1990, Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1, Nature, 347, 528, 10.1038/347528a0 Pfaffle, 1999, Combined pituirary hormone deficiency: role of Pit-1 and Prop-1, Acta Pædiatrica, 88, 33, 10.1111/j.1651-2227.1999.tb14401.x Yamamoto, 2011, Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans, J Clin Investig, 121, 113, 10.1172/JCI44073 Bando, 2014, Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome, J Clin Endocrinol Metab, 99, E1744, 10.1210/jc.2014-1769 Kanie, 2019, Pathogenesis of anti-PIT-1 antibody syndrome: PIT-1 presentation by HLA class I on anterior pituitary cells, J Endocr Soc, 3, 1969, 10.1210/js.2019-00243 Kamiya, 2009, Type 2 diabetes mellitus accompanied by isolated adrenocorticotropic hormone deficiency and gastric cancer, Intern Med, 48, 1031, 10.2169/internalmedicine.48.1972 Yamaguchi, 1997, Acute lymphoblastic leukemia with isolated adrenocorticotropic hormone deficiency, Intern Med, 36, 819, 10.2169/internalmedicine.36.819 Kubo, 1997, Isolated adrenocorticotropic hormone deficiency: an autopsy case of adrenal crisis: a case report, Am J Forensic Med Pathol, 18, 202, 10.1097/00000433-199706000-00020 Khare, 2015, Primary (autoimmune) hypophysitis: a single centre experience, Pituitary, 18, 16, 10.1007/s11102-013-0550-9 Thodou, 1995, Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings, J Clin Endocrinol Metab, 80, 2302 Nussbaum, 1991, Lymphocytic hypophysitis with involvement of the cavernous sinus and hypothalamus, Neurosurgery, 28, 440, 10.1227/00006123-199103000-00019 Pekic, 2018, Lymphocytic hypophysitis successfully treated with stereotactic radiosurgery: case report and review of the literature, J Neurol Surg A Cent Eur Neurosurg, 79, 77, 10.1055/s-0037-1604079 Tubridy, 2001, Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement, J Neurol Neurosurg Psychiatry, 71, 798, 10.1136/jnnp.71.6.798 Supler, 1992, Lymphocytic hypophysitis: report of a case in a man with cavernous sinus involvement, Surg Neurol, 37, 472, 10.1016/0090-3019(92)90138-D Zhu, 2019, Clinical features, magnetic resonance imaging, and treatment experience of 20 patients with lymphocytic hypophysitis in a single center, World Neurosurg, 127, e22, 10.1016/j.wneu.2019.01.250 Fleseriu, 2016, Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 101, 3888, 10.1210/jc.2016-2118 Honegger, 2015, Diagnosis of primary hypophysitis in Germany, J Clin Endocrinol Metab, 100, 3841, 10.1210/jc.2015-2152 Wang, 2017, Primary lymphocytic hypophysitis: clinical characteristics and treatment of 50 cases in a single centre in China over 18 years, Clin Endocrinol, 87, 177, 10.1111/cen.13354 Melmed, 2011, Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 96, 273, 10.1210/jc.2010-1692 Gubbi, 2000, Diagnostic testing for diabetes insipidus Gutenberg, 2011, Pituitary and systemic autoimmunity in a case of intrasellar germinoma, Pituitary, 14, 388, 10.1007/s11102-009-0187-x Husain, 2014, Idiopathic granulomatous hypophysitis presenting as pituitary apoplexy, J Clin Neurosci, 21, 510, 10.1016/j.jocn.2013.05.002 Ikeda, 1990, Lymphocytic adenohypophysitis accompanying occlusion of bilateral internal carotid arteries, Neurol Med Chir, 30, 346, 10.2176/nmc.30.346 Katoh, 2007, A clinically diagnosed lymphocytic hypophysitis presenting as recurrent meningitis, Rinsho shinkeigaku – Clin Neurol, 47, 419 Jain, 2015, A rare case of autoimmune hypophysitis presenting as temperature dysregulation, J Clin Diagn Res JCDR, 9, OD09 Richtsmeier, 1980, Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency, Arch Intern Med, 140, 1243, 10.1001/archinte.1980.00330200119034 Vasikaran, 1994, Secondary hypoadrenalism presenting with hypercalcaemia, Clin Endocrinol, 41, 261, 10.1111/j.1365-2265.1994.tb02540.x Ospina, 2016, ACTH stimulation tests for the diagnosis of adrenal insufficiency: systematic review and meta-analysis, J Clin Endocrinol Metab, 101, 427, 10.1210/jc.2015-1700 Christ-Crain, 2019, Diabetes insipidus, Nat Rev Dis Primers, 5, 1, 10.1038/s41572-019-0103-2 Araujo, 2015, Ipilimumab-induced hypophysitis: review of the literature, J Endocrinol Investig, 38, 1159, 10.1007/s40618-015-0301-z Tartaglione, 2018, Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis, Pituitary, 21, 414, 10.1007/s11102-018-0892-4 Nakata, 2010, Parasellar T2 dark sign on MR imaging in patients with lymphocytic hypophysitis, Am J Neuroradiol, 31, 1944, 10.3174/ajnr.A2201 Ahmadi, 1995, Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases, Radiology, 195, 30, 10.1148/radiology.195.1.7892490 Gutenberg, 2009, A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively, Am J Neuroradiol, 30, 1766, 10.3174/ajnr.A1714 Flanagan, 2002, Inflammatory hypophysitis–the spectrum of disease, Acta Neurochir, 144, 47, 10.1007/s701-002-8273-5 Holder, 1997, Magnetization transfer imaging of the pituitary: further insights into the nature of the posterior “bright spot”, J Comput Assist Tomogr, 21, 171, 10.1097/00004728-199703000-00002 Brooks, 1989, Frequency and variation of the posterior pituitary bright signal on MR images, Am J Roentgenol, 153, 1033, 10.2214/ajr.153.5.1033 Terano, 1996, Characteristics of the pituitary gland in elderly subjects from magnetic resonance images: relationship to pituitary hormone secretion, Clin Endocrinol, 45, 273, 10.1046/j.1365-2265.1996.00555.x Böttner, 2004, PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis, J Clin Endocrinol Metab, 89, 5256, 10.1210/jc.2004-0661 Honegger, 2015, Treatment of primary hypophysitis in Germany, J Clin Endocrinol Metab, 100, 3460, 10.1210/jc.2015-2146 Chiloiro, 2018, Hypophysitis outcome and factors predicting responsiveness to glucocorticoid therapy: a prospective and double-arm study, J Clin Endocrinol Metab, 103, 3877, 10.1210/jc.2018-01021 Albarel, 2019, Management of endocrine disease: immune check point inhibitors-induced hypophysitis, Eur J Endocrinol, 181, R107, 10.1530/EJE-19-0169 Joshi, 2016, Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review, Clin Endocrinol, 85, 331, 10.1111/cen.13063 Papanastasiou, 2011, Azathioprine as an alternative treatment in primary hypophysitis, Pituitary, 14, 16, 10.1007/s11102-010-0252-5 Ward, 1999, Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy, J Clin Endocrinol Metab, 84, 844 Schreckinger, 2012, Novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab: case report, J Neurosurg, 116, 1318 Bullock, 2018, Rituximab treatment for isolated IgG4-related hypophysitis in a teenage female, Endocrinol Diab Metabol Case Rep, 2018 2018, IgG4-related neuroinfundibulo-hypophysitis treated by rituximab and corticosteroids Ray, 2010, Gamma Knife surgery for lymphocytic hypophysitis: case report, J Neurosurg, 112, 118 Selch, 2003, Stereotactic radiotherapy for the treatment of lymphocytic hypophysitis: report of two cases, J Neurosurg, 99, 591 Chiloiro, 2018, Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis, Eur J Endocrinol, 178, 10.1530/EJE-17-0910 Kristof, 1999, Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy?, J Neurol Neurosurg Psychiatry, 67, 398, 10.1136/jnnp.67.3.398